Redhill Biopharma (STU:2RH) Total Noninterest Expense

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:2RH Redhill Biopharma Ltd STU:2RH
18 GF Score
Price €8.24
! 6 Warning Signs
View Full Analysis

What is Redhill Biopharma Total Noninterest Expense?

Total Noninterest Expense only applies to banks.

STU:2RH
18GF Score
Redhill Biopharma Ltd STU:2RH
Total Noninterest Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Redhill Biopharma Business Description

Other Exchanges RDHL:USA
Address 21 Ha’arba’a Street, Tel Aviv, ISR, 6473921
RedHill Biopharma Ltd is a specialty biopharmaceutical company focused on the development and commercialization of oral small-molecule drugs, primarily in the United States. Its commercial portfolio centers on gastrointestinal therapies, including Talicia, a rifabutin-based combination therapy for Helicobacter pylori infection, and Aemcolo (rifamycin) for travelers' diarrhea. The company also markets other GI-related products and generates revenue through U.S. product sales and, to a lesser extent, licensing and distribution arrangements. Its development pipeline includes opaganib, an oral sphingosine kinase-2 inhibitor studied in oncology and infectious disease indications, and RHB-107 (upamostat) for viral and inflammatory conditions, along with other clinical-stage candidates. RedHill is headquartered in Israel and conducts operations and sales mainly in the U.S. market, with additional activities in select international territories.
18GF Score

Get the complete analysis for STU:2RH

Total Noninterest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€8.24
Price